Vanberra Signal

Aperture Therapeutics

Curated by Signal

Provider of bioinformatics solutions for genetic drug discovery

Overview

Provider of bioinformatics solutions for genetic drug discovery. It is a digital drug discovery platform focusing on neurodegenerative diseases based on the genetic makeup of the patients and leverages a mechanistic understanding of protective gene variants in the human population.

Key facts

Founded
2022

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Online consultation platform for on-demand wellness coaching

    Health TechnologyNew York City, United States
  • AI-based personalized treatment management tool for providers

    Health TechnologyWaltham, United States
  • Provider of medical cannabis products

    Health TechnologyUnited States

About Aperture Therapeutics

What does Aperture Therapeutics do?

Provider of bioinformatics solutions for genetic drug discovery.

Where is Aperture Therapeutics headquartered?

Aperture Therapeutics is headquartered in San Carlos, United States.

When was Aperture Therapeutics founded?

Aperture Therapeutics was founded in 2022.

Which sector is Aperture Therapeutics in?

Aperture Therapeutics operates in Health Technology.

Who are Aperture Therapeutics's competitors?

Companies similar to Aperture Therapeutics include Mine'd, AVAVA Skin, and HOPE.